Wuhan Hiteck Biological Pharma Co Ltd
300683
Company Profile
Business description
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Contact
Hite Science and Technology Park
Wuhan Economic and Technological Development Zone
Hubei Province
Wuhan430056
CHNT: +86 2784599931
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,520
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,974.90 | 15.20 | 0.19% |
| CAC 40 | 7,273.12 | 168.32 | 2.37% |
| DAX 40 | 20,954.83 | 580.73 | 2.85% |
| Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
| FTSE 100 | 8,134.34 | 170.16 | 2.14% |
| HKSE | 21,471.53 | 54.13 | 0.25% |
| NASDAQ | 16,831.48 | 107.03 | 0.64% |
| Nikkei 225 | 34,311.79 | 329.43 | 0.97% |
| NZX 50 Index | 12,042.33 | 65.21 | -0.54% |
| S&P 500 | 5,405.97 | 42.61 | 0.79% |
| S&P/ASX 200 | 7,767.90 | 19.30 | 0.25% |
| SSE Composite Index | 3,257.69 | 5.12 | -0.16% |